Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: I.V.
Diamond Member Since 2022

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
Full Customization
The supplier provides full customization services
Experienced Team
The supplier has 6 foreign trading staff(s) and 4 staff(s) with over 6 years of overseas trading experience
Self-branded
The supplier has 2 Self-brands, check the Audit Report for more information
to see all verified strength labels (18)
  • Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
  • Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
  • Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
  • Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
  • Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
  • Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
Find Similar Products

Basic Info.

Model NO.
322.5mg/5ml
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Liquid
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Customised
Design
CAS
50-63-5
Quantity
Bulk
Market
African
Transport Package
Carton
Specification
322.5mg/5ml, 10amps, 100amps/box
Trademark
RYAN PHARMA
Origin
China

Product Description

Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
Chloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP PharmaceuticalChloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP PharmaceuticalChloroquine Phosphate Injection 322.5mg/5ml Bp Cp USP Pharmaceutical
Product name:Chloroquine Phosphate Injection
Category: Injection
Package:322.5mg/5ml×100ampoules/box
Packaging Details: As usual , we also can make as your requirement.
Function indications:
This product is used to treat patients with chloroquine sensitive falciparum malaria, Plasmodium vivax, Plasmodium Triticum and ovale malaria who can't be taken orally. It can also be used to treat patients with extraintestinal amoebiasis such as amoebic liver abscess. After the condition is improved, oral medicine will be used instead.
Usage and dosage:
Intravenous drip of 18-24 mg/kg was given to cerebral malaria patients on the first day (60 kg for those who weighed more than 60 kg), 12 mg/kg on the second day and 10 mg/kg on the third day. The concentration of chloroquine phosphate is 0.5g/min, added into 500ml of 10% glucose solution or 5% glucose and sodium chloride injection, and the intravenous infusion speed is 12-20 drops / min.
Adverse reactions:
May have photophobia, color vision damage, vision decline, severe blindness. It can also cause the inhibition of sinoatrial node, lead to arrhythmia, body gram, and even death.
Taboo:
It is forbidden for patients with liver and kidney dysfunction and heart disease.
matters needing attention:
1. Patients with severe erythema multiforme, porphyria, psoriasis and psychosis should be careful.
2. Chloroquine injection is not suitable for intramuscular injection, especially in children. Intravenous injection is prohibited.
3. Chloroquine can cause fetal hydrocephalus, limb deformity and deafness, so it is forbidden for pregnant women.
Medication for pregnant and lactating women:
It is forbidden for pregnant women and lactating women.
Medication for children:
The dosage is the same as that of adults, but intravenous administration should be cautious.
Medication for the elderly:
Elderly patients should be careful with intravenous administration.

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier